Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village

The U.S.FDA has issued an Establishment Inspection Report (EIR) against the Inspection conducted at our Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, from April 28, 2025 to May 2, 2025.

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 12118.80 as compared to the previous close of Rs. 11961.05. The total number of shares traded during the day was 786 in over 278 trades.

The stock hit an intraday high of Rs. 12175.10 and intraday low of 11908.60. The net turnover during the day was Rs. 9483615.00.

Source : Equity Bulls

Keywords

NeulandLaboratories INE794A01010 Pharmaceuticals USFDA EIR Unit2 PashamylaramVillage